SCHEDULE 13G/A: Omega Fund VI Discloses 3.6% Passive Stake in Lexeo Therapeutics
Beneficial Ownership Report
Omega Fund VI and its affiliates have disclosed a passive beneficial ownership of 3.6% in Lexeo Therapeutics, Inc., holding 1,184,636 shares of common stock as of December 31, 2024.
Summary
- Omega Fund VI, L.P., Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Claudio Nessi, Otello Stampacchia, and Francesco Draetta (collectively, the "Reporting Persons") have filed a Schedule 13G.
- The filing reports beneficial ownership of 1,184,636 shares of Common Stock in Lexeo Therapeutics, Inc.
- This ownership represents approximately 3.6% of Lexeo Therapeutics' common stock outstanding.
- The percentage is calculated based on 33,065,947 shares of common stock outstanding as of November 12, 2024, as reported in Lexeo Therapeutics' Quarterly Report on Form 10-Q filed on November 13, 2024.
- All Reporting Persons share both voting and dispositive power over the 1,184,636 shares.
Sentiment
Score: 5
Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G) indicating a passive stake, which typically has a neutral sentiment impact on the company's outlook or stock price.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant, passive ownership stake held by Omega Fund VI, L.P. and its related entities in Lexeo Therapeutics, Inc.
Key Dates
| Date | Description |
|---|---|
| 2024-11-12 | Date as of which 33,065,947 shares of common stock were outstanding, as reported in the Issuer's 10-Q. |
| 2024-11-13 | Date Lexeo Therapeutics' Quarterly Report on 10-Q for the period ended September 30, 2024, was filed with the SEC. |
| 2024-12-31 | Date of event which requires the filing of this Schedule 13G statement. |
| 2025-02-14 | Date this Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Lexeo Therapeutics, Omega Fund VI, Schedule 13G, beneficial ownership, common stock, SEC filing, investment fund, passive stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.